-- TransCode Therapeutics (RNAZ) filed a resale registration Thursday covering up to 1.53 million shares that YA II PN Ltd may sell from time to time.
YA II PN, also known as Yorkville, is the counterparty to the company's standby equity purchase agreement signed April 6, according to the preliminary prospectus filed with regulators.
The shares include 750,000 issuable upon conversion of convertible notes, 750,000 that may be issued through advances under the agreement, and 33,334 commitment shares. TransCode said it has received $950,000 from the sale of a convertible note and may receive up to $18.8 million more from additional note sales and share issuances under the facility.
TransCode will not receive proceeds from the selling stockholder's resale of the registered shares.
Price: $8.40, Change: $+0.39, Percent Change: +4.87%